However, the Kaplan–Meier plotter results indicated that although the survival rate of patients without TMPRSS2 alterations appeared to be worse, there were no significant differences in OS, DFS, PFS or disease-specific survival (DSS) between patients with lung cancer with alterations in TMPRSS2 and those without alterations in TMPRSS2 (Supplementary Figure 4C). The gene discussed is TMPRSS2; the disease is lung cancer.